Skip to content

Central mechanism of acupuncture for chronic angina: a randomized controlled trial

Evaluation of appropriate populations for acupuncture in the treatment of angina based on brain-cardiac multidimensional data features

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088715
Enrollment
Unknown
Registered
2024-08-26
Start date
2024-08-30
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

angina

Interventions

Group 1:acupuncture at neiguan and tongli with thumbtack intradermal needle
Group 2:sham acupuncture at neiguan and tongli with thumbtack intradermal needle

Sponsors

Bishan Hospital of Chongqing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of stable coronary heart disease in the Guidelines for Diagnosis and Treatment of Stable Coronary Heart Disease in 2018; 2. Meet Grade I or II in CCS angina severity grading standard; 3. 45 years old <= age <= 65 years old; 4. The onset time is greater than or equal to 3 months, and the number of attacks per week in the past month is 2 or more; 5. At least 2 months of standard basic drug treatment history before joining the group (maintaining the same drug, usage and dosage); 6. Good compliance, willing to cooperate with the study, and the patient signed an informed consent form; 7. Right-handed.

Exclusion criteria

Exclusion criteria: 1. Pregnant and breastfeeding women, those who have childbearing requirements in the past six months; 2. Turned into acute coronary syndrome, severe arrhythmia; 3. drug abuse or alcohol abuse; 4. Those with severe mental illness and intellectual disability who cannot cooperate with the questionnaire; 5. Failure to control high blood pressure 5 or diabetes 5; 6. Those who have received acupuncture treatment due to cardiovascular disease in the past 1 month; 7. Patients with bleeding tendency and skin diseases; 8. Those who are participating in other clinical trials; 9. Subjects participating in the fMRI trial part also need to exclude: MRI contraindications, such as metal implants in the body, claustrophobia, etc.

Design outcomes

Primary

MeasureTime frame
The frequency of angina attack during 4-week;

Secondary

MeasureTime frame
Seattle Angina Questionnaire;Severity of angina pectoris (visual analogue scale);CCS angina severity grade;Self-rating anxiety scale;Self-rating depression scale;Montreal Cognitive Assessment;Expectation evaluation of acupuncture ;

Countries

China

Contacts

Public ContactChangqing Yu

Bishan Hospital of Chongqing

85669650@qq.com+86 155 2838 5250

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026